Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Folic acid

This article was originally published in The Tan Sheet

Executive Summary

Multi-center trial to evaluate effects of folate supplementation on occurrence of Down's syndrome underway following research finding link between disorder and neural tube defects. Gad Barkai, Tel Aviv University, et al., studied women in Israel and the Ukraine, finding "periconceptional folic acid supplementation should be recommended" for mothers who have already had a child with Down's syndrome, since they are likely at an increased risk for having another child with neural tube defects. Study in April 19 The Lancet followed 493 families in Israel with high NTD risk, 516 families in the Ukraine with high risk for Down's syndrome. Barkai et al. examined medical records with information on maternal age, pregnancy outcome and congenital malformations...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS095393

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel